The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.

A new study found that women who received mail-in self-collection kits participated in screening at much higher rates than those who just received a telephone reminder.

Called Velo, the system can perform true PCR testing in 10 minutes or less and is intended for use in decentralized spaces.

The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.

NEW YORK – Randox Laboratories said this week that it has secured US Food and Drug Administration de novo marketing authorization for a companion diagnostic immunoassay to help determine the ...

NEW YORK – QuidelOrtho announced after the close of the market on Tuesday that it will discontinue development of its Savanna molecular diagnostic system and that it aims to acquire UK-based Lex ...

The BLIPI test device was used to monitor babies' immune status from a drop of whole blood and detected sepsis within 15 minutes, enabling incubator-side testing.

CHICAGO – A team of researchers from Memorial Sloan Kettering Cancer Center has developed a Pap-based assay for endometrial cancer that is able to detect higher amounts of cell-free DNA than blood ...

NEW YORK – Danaher subsidiary Cepheid announced Wednesday that its Xpert HIV-1 Viral Load XC assay has received a medical device license from Health Canada. The next-generation extended coverage test ...

The RiskReveal assay was used to determine which early-stage non-squamous NSCLC patients should undergo adjuvant chemotherapy ...